BerandaGLAXO • NSE
add
GlaxoSmithKline Pharmaceuticals Ltd
Tutup sebelumnya
₹2.473,60
Rentang hari
₹2.442,50 - ₹2.476,00
Rentang tahun
₹1.921,00 - ₹3.515,70
Kapitalisasi pasar
415,61 M INR
Volume Rata-Rata
92,20 rb
Rasio P/E
43,56
Hasil dividen
1,71%
Bursa utama
NSE
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (INR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 9,80 M | -3,05% |
Biaya operasional | 3,06 M | -4,77% |
Penghasilan bersih | 2,57 M | 1,98% |
Margin laba bersih | 26,28 | 5,20% |
Penghasilan per saham | — | — |
EBITDA | 3,35 M | 4,13% |
Tarif pajak efektif | 27,26% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 20,61 M | -2,36% |
Total aset | 36,65 M | -2,16% |
Total liabilitas | 19,57 M | -5,59% |
Total ekuitas | 17,08 M | — |
Saham yang beredar | 169,40 jt | — |
Harga terhadap nilai buku | 24,54 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 42,96% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 2,57 M | 1,98% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Didirikan
13 Nov 1924
Situs
Karyawan
3.113
